Status and phase
Conditions
Treatments
About
A randomized, double-blind, parallel controlled, multicenter clinical trial to compare the efficacy and safety of LY09004 and EYLEA in the Treatment of Wet Age-related Macular Degeneration(wAMD)
Full description
This is a randomized, double-blind, parallel controlled, multicenter clinical trial.
The primary objective is to assess the efficacy similarity of LY09004 and EYLEA in the treatment of w-AMD.
The secondary objective is to assess the safety similarity of LY09004 and EYLEA in the treatment of w-AMD.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
416 participants in 2 patient groups
Loading...
Central trial contact
Youxin Chen
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal